Crisil provides credit ratings, financial research, and risk analytics to global banks, investment firms, and Indian corporations. It earns revenue through fees for rating debt instruments and subscription-based or project-led analytical services.
The company possesses a wide moat driven by regulatory licenses in the Indian rating market and high switching costs in global benchmarking. This is corroborated by exceptionally high and stable ROCE (40%) and net margins (20%) which have persisted despite global banking volatility.
Management maintains a highly disciplined, asset-light model with zero debt and high dividend payouts (56-62%). Capital is selectively deployed for strategic acquisitions like PriceMetrix to expand into wealth management adjacencies while maintaining high returns on equity.
The investment collapsed as the global banking sector entered a prolonged retrenchment, causing discretionary spending in the Global Research & Risk Solutions segment to evaporate. Simultaneously, the parent company, S&P Global, shifted its strategic priorities, reducing the volume of related-party business that previously accounted for a tenth of revenue. This double-whammy of shrinking demand and weakened parent support exposed the high fixed-cost nature of their talent pool, leading to a rapid compression of the once-pristine 20% net margins and a re-rating of the stock to a much lower multiple.
RichFakir rates CRISIL Ltd's business quality as wonderful — 88/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as wide.
On our model, CRISIL Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on CRISIL Ltd is: Watch — wait for price. A wonderful business, but at an expensive price against our estimate of fair value — one to keep on the watchlist for a better entry.
RichFakir's educational estimate of CRISIL Ltd's fair value is about ₹2,230 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →